The Evolution of Epigenetic Biomarkers: Methylation and similar DNA biomarkers, combined with liquid biopsy, may offer better testing options for difficult cancers

Niamh E Buckley, Laura Feeney, James Beirne, Paul Mullan

Research output: Other contribution

Abstract

At a Glance

Tissue biopsies serve a valuable purpose – but they are far from perfect
Liquid biopsy may be a better option, if we can overcome its technical limitations
Ovarian cancer is one disease that can benefit from better biomarkers and better assays
Epigenetic biomarkers, such as methylation, may improve sensitivity and specificity in the diagnosis of ovarian cancer
Original languageEnglish
PublisherThe Pathologist
Publication statusPublished - 02 Jan 2019

Fingerprint Dive into the research topics of 'The Evolution of Epigenetic Biomarkers: Methylation and similar DNA biomarkers, combined with liquid biopsy, may offer better testing options for difficult cancers'. Together they form a unique fingerprint.

Cite this